Trials / Completed
CompletedNCT05547087
A Dose Finding Study of VN-0200
A Phase 2, Randomized, Double-Blind, Dose Finding Study to Describe the Immunogenicity, Safety and Tolerability of VN-0200 in Japanese Adults Aged 60-80 Years
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 342 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the immunogenicity, safety and tolerability of VN-0200 after intramuscular injections in Japanese healthy elderly subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | VN-0200 | VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection; 2 shots in 4 weeks. |
Timeline
- Start date
- 2022-10-13
- Primary completion
- 2023-04-11
- Completion
- 2024-02-15
- First posted
- 2022-09-21
- Last updated
- 2024-02-29
Locations
3 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT05547087. Inclusion in this directory is not an endorsement.